Abstract: The present disclosure relates to a circuit providing protection against ground faults and over-voltages.

Abstract: The present disclosure relates to a circuit providing protection against ground faults and over-voltages.

Abstract: A pump comprising a housing comprising a rotor chamber, inlet and outlet channels opening into the rotor chamber, and inlet and outlet seals mounted on a surface of the chamber, and a rotor rotatably and axially slidably received in the chamber and comprising a first axial extension comprising a liquid supply channel and a second axial extension comprising a liquid supply channel, the first and second axial extensions having different diameters. The inlet and outlet seals engage a surface of the rotor, whereby the liquid supply channel of each axial extension in conjunction with a corresponding seal forms a valve that opens and closes as a function of the angular and axial displacement of the rotor. At least one of the inlet and outlet channels opens transversely into the rotor chamber and at least one of the inlet and outlet seals forms a closed circuit circumscribing said at least one of the inlet and outlet channels.

Abstract: A pump comprising a housing comprising a rotor chamber, inlet and outlet channels opening into the rotor chamber, and inlet and outlet seals mounted on a surface of the chamber, and a rotor rotatably and axially slidably received in the chamber and comprising a first axial extension comprising a liquid supply channel and a second axial extension comprising a liquid supply channel, the first and second axial extensions having different diameters. The inlet and outlet seals engage a surface of the rotor, whereby the liquid supply channel of each axial extension in conjunction with a corresponding seal forms a valve that opens and closes as a function of the angular and axial displacement of the rotor. At least one of the inlet and outlet channels opens transversely into the rotor chamber and at least one of the inlet and outlet seals forms a closed circuit circumscribing said at least one of the inlet and outlet channels.

Abstract: This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherein A and B are further defined in the application.

Abstract: This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherein A and B are further defined in the application.

Abstract: This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherein A and B are further defined in the application.

Abstract: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be useful for inhibiting the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway.

Abstract: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.

Abstract: The invention relates to a positioning instrument (1) for inserting an extension shell (2) into a human or animal bone, especially a pelvic bone. Said instrument comprises a fixing device (18) for fixing the extension shell (2) to the positioning instrument (1), and a displacement device (55) for displacing a disc element (15) of the positioning instrument (1) at least essentially axially in relation to the extension shell (2) fixed to the fixing device (18). Said disc element (15) co-operates with beveled surfaces (25a to 25e) of the extension shell (2) during the displacement, in order to tighten the extension shell (2). Furthermore, the disc element (15)-viewed in the direction of insertion (13)-does not project beyond the radially furthest projecting elements (32a, 32b) of the tightened extension shell (2).

Abstract: The invention relates to an expandable socket (1) for a hip joint endoprosthesis able to be cementlessly anchored in place which is at least approximately hemispherical and which is provided with a plurality of slots (3) extending in a meridional direction, thus forming intervening tongues (4), on which are formed projections (5) that form a plurality of rows (6; 6a, 6b) extending from an equator (2) of the expandable socket (1). The projections (5) are arranged on the tongues (4) in such a manner that a row (6a) of projections (5) arranged in the center of the tongue (4) extends on a meridian (14) of the hemispherical socket (1) while at least one adjoining row (6b) of projections (5) extends in a line that extends at all points in parallel to the meridian (14) of the row (6a) of projections (5) arranged in the center and not through a pole (10) of the hemispherical expandable socket (1).

Abstract: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.

Abstract: The invention relates to an expandable socket (1) for a hip joint endoprosthesis able to be cementlessly anchored in place which is at least approximately hemispherical and which is provided with a plurality of slots (3) extending in a meridional direction, thus forming intervening tongues (4), on which are formed projections (5) that form a plurality of rows (6; 6a, 6b) extending from an equator (2) of the expandable socket (1). The projections (5) are arranged on the tongues (4) in such a manner that a row (6a) of projections (5) arranged in the centre of the tongue (4) extends on a meridian (14) of the hemispherical socket (1) while at least one adjoining row (6b) of projections (5) extends in a line that extends at all points in parallel to the meridian (14) of the row (6a) of projections (5) arranged in the centre and not through a pole (10) of the hemispherical expandable socket (1).